<?xml version="1.0" encoding="UTF-8"?>
<urlset
  xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://glpwatchdog.org/research/hhs-peptide-compounding-policy-2026</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>HHS Peptide Compounding Policy (October 2026): The Six Peptides and Ten Conditions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/bpc-157-side-effects</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>BPC-157 Side Effects: What Is Known in People, and What Nobody Has Measured</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/bpc-157-dosage-in-the-studies</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>BPC-157 Dosage: What the Human Studies Actually Gave</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/peptide-blends-and-stacks</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>BPC-157 and TB-500 Together: Blends, Stacks and the HHS Single-Ingredient Rule</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/oral-bpc-157-capsules</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>BPC-157 Capsules: Oral BPC-157, the HHS Policy and What Is Known About Absorption</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/mots-c-dosage-and-side-effects</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>MOTS-c Dosage and Side Effects: What Has Been Tested in People</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/tb-500-side-effects-and-dosing</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>TB-500 Side Effects and Dosing: Whose Safety Data Are They?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/semax-vs-selank</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>Semax vs Selank: Two Russian Nasal Peptides, and Only One Is Now Covered</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/fda-approved-peptides</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>FDA-Approved Peptides: The Verified List, and What Is Not on It</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/what-is-peptide-therapy</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>What Is Peptide Therapy? Approved Drugs, Compounded Peptides and Research Vials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/research-use-only-vs-compounded-peptides</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>Research Use Only vs Compounded Peptides: What the Label Means Legally</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/fda-warning-letters-to-peptide-sellers</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/peptides-alongside-a-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>BPC-157, MOTS-c and Other Peptides With Semaglutide or Tirzepatide</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/peptide-blood-work-and-monitoring</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>Peptide Blood Work: Which Labs a Label Requires and Which Are Sold as a Package</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/kpv-oral-and-topical</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>KPV Capsules and Cream: Oral and Topical KPV Under the HHS Peptide Policy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/is-rybelsus-being-discontinued</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>Is Rybelsus Being Discontinued? What Happened and the Ozempic Pill Switch</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/rybelsus-for-weight-loss</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>Rybelsus for Weight Loss: How Much Weight People Lose, and Why It&apos;s Less</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/ozempic-tablets-explained</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>Ozempic Pill (Ozempic Tablets): Doses, How to Take It, Cost and the Wegovy Pill</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/epitalon-dosage-and-courses</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>Epitalon Dosage and Courses: What the Studies Used and What HHS Allows</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://glpwatchdog.org/research/peptides-for-weight-loss</loc>
    <news:news>
      <news:publication>
        <news:name>GLP Watchdog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T00:00:00.000Z</news:publication_date>
      <news:title>Peptides for Weight Loss: Every One Sold, Ranked by Human Evidence</news:title>
    </news:news>
  </url>
</urlset>